ADAR1 Capital Management »

Wave Life Sciences shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Wave Life Sciences (WVE) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Wave Life Sciences

Tip: Access up to 7 years of quarterly data

All positions including Wave Life Sciences held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Wave Life Sciences by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $185k 30k 6.17

More positions owned by ADAR1 Capital Management

Alnylam Pharmaceuticals (ALNY)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Roivant Sciences SHS (ROIV)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Protagonist Therapeutics (PTGX)
Cytokinetics Com New (CYTK)
Keros Therapeutics (KROS)
Royalty Pharma Shs Class A (RPRX)
Bridgebio Pharma (BBIO)
Merrimack Pharmaceuticals In Com New
Ascendis Pharma A/s Sponsored Adr (ASND)
Arbutus Biopharma (ABUS)
Avrobio Ord (AVRO)
Beigene Sponsored Adr (BGNE)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)

View all positions for ADAR1 Capital Management

Top funds holding Wave Life Sciences

RA Capital Management
Maverick Capital
BlackRock
BlackRock
M28 Capital Management
Driehaus Capital Management
Siren
683 Capital Management
Bellevue Group
Kynam Capital Management
T. Rowe Price Associates
Emerald Advisers
PRIMECAP Management Company
Vanguard Group
Geode Capital Management

View all funds holding Wave Life Sciences